Laskowitz, D
Water for Injection: Solvent that carries all the ingredients, allowing the medication to be administered via injection
Is there a mechanism behind it
Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a Cohort Study using the UK Clinical Practice Research Datalink
The MHRA ( Medicines and Healthcare products Regulatory Agency ) has two main application procedures: Simple Reclassification : This is a straightforward and quick procedure based on an analogous product (a medicinal product already on the UK market with the same active ingredient, route of administration, use, and a similar or higher strength/dosage)
In my practice, I view it as a complementary, not competitive, ingredient: a reasonable addition for women who cannot tolerate retinoids, or as part of a layered approach for those who can